SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
SCHOTT Pharma AG & Co KgaA
Cash from Financing Activities
SCHOTT Pharma AG & Co KgaA
Cash from Financing Activities Peer Comparison
GXI
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Cash from Financing Activities
-€11.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
E
|
Evotec SE
XETRA:EVT
|
Cash from Financing Activities
€66.1m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
8%
|
|
|
Gerresheimer AG
XETRA:GXI
|
Cash from Financing Activities
-€3.6m
|
CAGR 3-Years
64%
|
CAGR 5-Years
39%
|
CAGR 10-Years
17%
|
See Also
What is SCHOTT Pharma AG & Co KgaA's Cash from Financing Activities?
Cash from Financing Activities
-11.4m
EUR
Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Cash from Financing Activities amounts to -11.4m EUR.
What is SCHOTT Pharma AG & Co KgaA's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
8%
Over the last year, the Cash from Financing Activities growth was 73%. The average annual Cash from Financing Activities growth rates for SCHOTT Pharma AG & Co KgaA have been 8% over the past three years .
You don't have any saved screeners yet
